Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap93.88B
Enterprise Value103.03B
Trailing P/E32.02
Forward P/E20.52
BSX
(NYSE)Boston Scientific Corporation
$62.82-- (--)
Loading... - Market loading
Boston Scientific (BSX) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)4.62
Forward Price/Sales3.85
Price/Book (mrq)3.82
Price/FCF (ttm)26.64
Price/OCF (ttm)20.44
PEG Ratio0.57
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue5.13
EV/Earnings35.60
EV/EBITDA21.01
EV/EBIT28.55
EV/FCF29.62
Stock Price
Current price, 52-week range, and moving averages
Current Price$62.82
1-Day Change-1.20%
52-Week High$109.50
52-Week Low$61.25
52-Week Change-38.76%
YTD Change-34.54%
1-Year Change-38.03%
50-Day MA$76.13
200-Day MA$94.40
Avg Volume (30 day)13.89M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding1.49B
Book Value per Share$16.21
Net Cash per Share$1.11
FCF per Share$2.33
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$102.13
Target Upside/Downside62.58%
Analyst ConsensusBuy
Analyst Count31
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin70.30%
EBITDA Margin (ttm)24.42%
EBIT Margin (ttm)17.98%
Operating Margin (ttm)20.60%
Pretax Margin (ttm)16.86%
Profit Margin (ttm)14.42%
FCF Margin (ttm)17.33%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)11.94%
Return on Assets (ttm)6.63%
Return on Invested Capital (ttm)8.92%
Return on Capital Employed (ttm)9.44%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue20.07B
Gross Profit14.11B
Operating Income4.14B
Pretax Income3.38B
Net Income2.89B
EBITDA4.90B
EBIT3.61B
Diluted EPS$1.93
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow4.53B
Capital Expenditures1.06B
Free Cash Flow3.48B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth19.87%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)43.67B
Cash & Securities (mrq)2.04B
Net Cash (mrq)1.66B
Net Cash per Share$1.11
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)12.42B
Working Capital (mrq)3.35B
Total Equity (mrq)24.23B
Book Value per Share$16.21
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.62
Quick Ratio (mrq)1.08
Debt/Equity (mrq)0.51
Debt/EBITDA (ttm)2.53
Debt/FCF (ttm)3.57
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield3.12%
FCF Yield3.75%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score3.90
Piotroski F-Score7/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$108.69
Lynch Upside/Downside75.30%
Graham Number$26.57
Graham Upside/Downside-57.15%
Frequently Asked Questions About Boston Scientific Statistics
What are the key financial metrics for BSX?
Boston Scientific Corporation (BSX) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is BSX's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Boston Scientific is overvalued or undervalued.
How do I read BSX's profitability ratios?
Boston Scientific's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do BSX's debt ratios indicate?
The financial health section shows Boston Scientific's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is BSX's dividend analysis?
The dividend section covers Boston Scientific's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.